Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Biological features of primary APL blasts: their relevance to the understanding of granulopoiesis, leukemogenesis and patient management

Oncogene volume 20, pages 7154–7160 (2001)Cite this article

Abstract

In recent years, discovery of the in vitro and in vivo differentiation of APL blasts by all-trans retinoic acid (ATRA) has modified the therapeutic approach of APL and lead to important advances in understanding the biology of APL. Since it became apparent that differentiation therapy of APL with ATRA was indeed a true model of targetted therapy, evidencing the molecular targets of retinoic acid efficacy became crucial. These molecular targets are closely related to the biological features of APL cells, some of which are well-known and have contributed to the morphological and cytogenetic definition of the leukemia, others have just been defined or re-discovered in the light of a better understanding of molecular controls of cell growth and differentiation. The aims of characterizing the biological features of APL cells should allow a better management of APL therapy and the identification of potential markers for differentiation therapies in other leukemias or solid tumors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  • Agadir A, Cormic M, Lefebvre P, Gourmel B, Jerome M, Degos L, Fenaux P, Chomienne C . 1995a J. Clin. Oncol. 13: 2517–2523

  • Agadir A, Cornic M, Jerome M, Menot ML, Cambier N, Gaub MP, Gournmel B, Lefebvre P, Degos L, Chomienne C . 1995b BBRC 213: 112–122

  • Allford S, Grimwade D, Langabeer S, Duprez E, Saurin A, Chatters S, Walker H, Roberts P, Rogers J, Bain B, Patterson K, McKernan A, freemont P, Solomon E, Burnett A, Goldstone A, Linch D . 1999 Br. J. Haematol. 105: 198–207

  • Altucci L, Rossin A, Raffelsberger W, Reitmair A, Chomienne C, Gronemeyer H . 2001 Nature Medecine 7: 680–686

  • Arnould C, Philippe C, Bourdon V, Grégoire MJ, Berger R, Jonveaux P . 1999 Hum. Mol. Gen. 8: 1741–1749

  • Belaaouaj A, Moog Lutz C, Just J, Houzel Charavel A, Shapiro SD, Cayre Y . 1999 Mamm. Genome 10: 210–212

  • Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C . 1976 Br. J. Haematol. 33: 451–458

  • Calabresse C, Barbey S, Venturini L, Balitrand N, Degos L, Fenaux P, Chomienne C . 1995 Leukemia 9: 2049–2057

  • Cassinat B, Balitrand N, Zassadowski F, Barbey C, Delva L, Bastie JN, Rain JD, Degos L, Fenaux P, Chomienne C . 1998 Blood 92: 596a

  • Cassinat B, Chevret S, Zassadowski F, Balitrand N, Guillemot I, Degos L, Fenaux P, Chomienne C . 2001 Blood in press

  • Chang KS, Wang G, Freireich EJ, Daly M, Naylor SL, Trujillo JM, Stass SA . 1992 Blood 79: 1802–1810

  • Chambon P . 1996 Faseb J. 10: 940–954

  • Charrad RS, Li Y, Delpech B, Balitrand N, Clay D, Jasmin C, Chomienne C, Smadja-Joffe F . 1999 Nature Medecine 5: 669–676

  • Chelbi-Alix MK, Pelicano L . 1999 Leukemia 13: 1167–1174

  • Chomienne C, Ballerini P, Balitrand N, Daniel MT, Fenaux P, Castaigne S, Degos L . 1990 Blood 76: 1710

  • Chomienne C, Balitrand N, Ballerini P, Castaigne S, De The H, Degos L . 1991 J. Clin. Inves. 88: 2150–2154

  • Chomienne C, Fenaux P, Degos L . 1996 Faseb J. 10: 1025–1030

  • Collins SJ, Roberton Ka, Le Moyne Mueller . 1990 Mol. Cell. Biol. 10: 2154–2163

  • Da Silva N, Meyer-Monard S, Menot ML, Parrado A, Lebel A, Balitrand N, Fenaux P, Micléa JM, Rousselot P, Degos L, Dombret H, Chomienne C . 2000 Hematol. J 1: 316–332

  • De Botton S, Dombret H, Sanz M, Miguel JS, Caillot D, Zittoun R, Gardembas M, Stamatoulas A, Conde E, Guerci A, Gardin C, Geiser K, Makhoul DC, Reman O, de la Serna J, Lefrere F, Chomienne C, Chastang C, Degos L, Fenaux P . 1998 Blood 92: 2712–2718

  • De Botton S, Chevret S, Sanz M, Dombret H, Thomas X, Guerci A, Fey M, Rayon C, Huguet F, Sotto JJ, Gardin C, Cony makhoul P, Travade P, Solary E, Fegueux N, Bordessoule D, San Miguel J, Link H, Desablens B, Stamatoullas A, Deconinck E, Geiser K, Hess U, Maloisel F, Castaigne S, Preudhomme C, Chomienne C, Degos L, Degos L, for the European APL Group . 2000 Br. J. Haematol. 111: 801–806

  • De Gentile A, Toubert ME, Dubois C, Krawice I, Schlageter MH, Balitrand N, Castaigne S, Degos L, Rain JD, Najean Y, Chomienne C . 1994 Leukemia 8: 1758–1762

  • Delva L, Cornic M, Balitrand N, Guidez F, Miclea JM, Delmer A, Treillet F, Fenaux P, Castaigne S, Degos L, Chomienne C . 1993 Blood 82: 2175–218

  • Delva L, Bastie JN, Rochette-Egly C, Kraïba R, Balitrand N, Despouy G, Chomienne C . 1999 Mol. Cell. Biol. 19: 7158–7167

  • Ding W, Li YP, Nobile LM, Grills G, Carrera I, Paietta E, Tallman MS, Wiemik PH, Gallagher RE . 1998 Blood 92: 1172–1183

  • Dombret H, Scrobohaci ML, Ghorra P, Zini JM, Daniel MT, Castaigne S, Degos L . 1993 Leukemia 7: 2–9

  • Douer D, Estey E, Santillana S, Bennet JM, Lopez-Bernstein G, Boehm K, Williams T . 2001 Blood 97: 73–80

  • Dubois C, Schlageter MH, De Gentille A, Guidez F, Balitrand N, Toubert ME, Krawice I, Fenaux P, Castaigne S, Najean Y, Degos L, Chomienne C . 1991 Blood 83: 3264–3270

  • Dubois C, Schlageter MH, De Gentille A, Guidez F, Balitrand N, Toubert ME, Krawice I, Fenaux P, Castaigne S, Najean Y, Degos L, Chomienne C . 1994 Leukemia 8: 1750–1757

  • Duprez E, Benoit G, Flexor M, lillehaug JR, Lanotte M . 2000 Leukemia 14: 255–256

  • Exner M, Thalhammer R, Kapiotis S, Mitterbauer G, Knobl P, Haas OA, Jager U, Schwarzinger I . 2000 Cytometry 42: 106–109

  • Fenaux P, Chastang C, Chevret S, Sanz M, Dombret H, Archimbaud E, Fey M, Rayon C, Huguet F, Sotto JJ, Gardin C, Cony Makhoul P, Travade P, Solary E, Fegueux N, Bordessoule D, San Miguel J, Link H, Desablens B, Stamatoullas A, Deconinck E, Maloisel F, Castaigne S, Preudhomme C, Degos L, for the European APL Group . 1999 Blood 94: 1192–1200

  • Ferrara F, Marabito F, Martino B, Specchia G, Liso V, Nobile F, Boccuni P, Di Noto R, Pane F, Annunziata M, Schiavone EM, De Simone M, Guglielmi C, Del Vecchio L, Lo Cocco F . 2000 J. Clin. Oncol. 18: 1295–1300

  • Foley R, Soamboonsrup P, Carter RF, Benger A, Meyer R, Walker I, Wan Y, Patterson W, Orzel A, Sunisloe L, Leber B, Neame PB . 2001 Am. J. Hematol. 67: 34–41

  • Gallagher RE, Li YP, Rao S, Paietta E, Andersen J, Etkind P, Bennet JM, Tallman MS, Wiernik PH . 1995 Blood 86: 1540–1547

  • Garattini E, Gianni M . 1996 Leuk. Lymphoma 23: 493–503

  • Gjersten MK, Bakka A, Breivik J, Saeterdal I, Solheim BG, Soreide O, Thorsby E, Gaudernack G . 1995 Lancet. 346: 1399–1400

  • Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E, Biondi A, Lo Coco F, Grignani F, Pelicci PG . 1994 Blood 83: 10–25

  • Grimwade D, Bion di A, Mozziconacci MJ, Hagemeijer A, Berger R, Neat M, Howe K, Dastugue N, Jansen J, Radford-Weiss I, Lo Cocco F, Lessard M, Hernandez JM, Delabesse E, Head D, Liso V, Sainty D, Flandrin G, Solomon E, Birg F, Lafage-Pochitaloff M . 2000 Blood 96: 1297–1308

  • Guglielmi C, Martelli MP, Diverio D, Fenu S, Vegna ML, Cantu-Rajnoldi A, Biondi A, Cocito MG, Del Vecchio L, Tabilio A, Avvisati G, Basso G, Lo Cocco F . 1998 Br. J. Haematol. 102: 1035–1041

  • Guidez F, Huang W, Tong JH, Dubois C, Balitrand N, Waxman S, Michaux JL, Martiat P, Degos L, Chen, Chomienne C . 1994 Leukemia 8: 312–317

  • Guidez F, Ivins S, Zhu J, Söderström M, Waxman S, Zelent A . 1998 Blood 91: 2634

  • He LZ, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A, Pandolfi PP . 1998 Nat. Genet. 18: 126–135

  • Heinzel T, Lavinski R, Mullen T, Söderström M, Laherty C, Torchia J, Yang WM, Brard G, Ngo S, Davie J, Seto E, Eisenman R, Dose D, Glass C, Rosenfeld M . 1997 Nature 387: 43

  • Hsu HC, Tsai WH, Chen PG, Hsu ML, Ho CK, Wang SY . 1999 Eur. J. Haematol. 63: 11–18

  • Imaizumi M, Suzuki H, Yoshinari M, Sato A, Saito T, Sugawara A, Tsuchiya S, Hatae Y, Fujimoto T, Kakizuka A, Konno T, Iinuma K . 1998 Blood 92: 374–382

  • Jansen JH, de Ridder MC, Geertsma WM, Erpelinck CA, Van Lom K, Smit EM, Slater R, vd Reijden BA, de Greef GE, Sonneveld P, Lowenberg B . 1999 Blood 94: 39–45

  • Jurgic JG, Caron PC, Miller WH, Yao TJ, Maslak P, Finn RD, Larsoon SM, Warrel RP, Scheinberg DA . 1995 Leukemia 2: 244–248

  • Kitamura K, Kiyoi H, Yoshida H, Saito H, Ohno R, Naoe T . 1997 Leukemia 11: 1950–1956

  • Lallemand-Breitenbach V, Guillemin MC, Janin A, Daniel MT, Degos L, Kogan SC, Bishop JM, De Thé H . 1999 J. Exp. Med. 189: 1043–1052

  • Larson RA, Kondo K, Vardiman JW, Butler ARE, Golomb HM, Rowley JD . 1984 Am. J. Med. 76: 827–841

  • Launay S, Gianni M, Kovacs T, Bredoux R, Bruel A, Gelebart P, Zassadowski F, Chomienne C, Enouf J, Papp B . 1999 Blood 93: 4395–4405

  • Licht JD, Chomienne C, Goy A, Chen A, Scott AA, Head DR, Michaux JL, Wu Y, Deblasio A, Miller WH . 1995 Blood 85: 1083–1094

  • Lin RJ, Nagy L, Inoue S, Shao W, Miller Jr WH, Evans RM . 1998 Nature 391: 811–814

  • Marks PA, Richon VM, Rifkind RA . 2000 J. Natl. Cancer Inst. 92: 1210–1216

  • Martin SJ, Bradley JG, Cotter TG . 1990 Clin. Exp. Imm. 79: 448–453

  • Miyauchi J, Ohyashidi K, Inatomi Y, Toyama K . 1997 Blood 90: 803–813

  • Mologoni L, Ponzanelli I, Bresciana F, Sarceillo G, Bergamaschi D, Gianni M, Reichert U, Rambaldi A, Terao M, Garattini E . 1999 Blood 93: 1045–1061

  • Morosetti R, Park DJ, Chumakov AM, Grillier I, Shiohara M, Gombart AF, Nakamaki T, Weinberg K, Koeffler HP . 1997 Blood 90: 2591–2600

  • Muindi J, Frankel SR, Miller WH, Jakubowski A, Scheinberg DA, Young CW, Dimitrowsky E . 1992 Blood 79: 299

  • Napoli JL . 1996 FASEB J. 10: 993–1001

  • Neame PB, Soamboonsrup P, Leber B, Carter RF, Sunisloe L, Patterson W, Orzel A, Bates S, McBride JA . 1997 Am. J. Hematol. 56: 131–142

  • Niu C, Yan H, Yu T, Sun HP, Liu JX, Li XS, Wu W, Zhang FQ, Chen Y, Zhou L, Li JM, Zeng XY, Yang RR, Uan MM, Ren MY, Gu FY, Cao Q, Gu BW, Su XY, Chen GQ, Xiong SM, Zhang TS, Waxman S, Wang ZY, Chen SJ et al. 1999 Blood 94: 3315–3324

  • Novitch S, Camacho L, Gallagher R, Chanel S, Ho R, Tolentino T, Richon V, Pandolfi PP, Warrel RP . 1999 Blood 94: 61a

  • Paietta E, Andersen J, Gallagher R, Bennet J, Yunis J, Cassileth P, Rowe J, Wiernik PH . 1994 Leukemia 8: 1108–1112

  • Park DJ, Chumakov AM, Vuong PT, Chih DY, Gombart AF, Miller Jr WH, Koeffler HP . 1999 J. Clin. Invest. 103: 1399–1408

  • Parrado A, Noguera ME, Delmer A, Mc Kenna S, Davies J, Le Gall I, Bentley P, Whitthaker J, Sigaux F, Chomienne C, Padua RA . 2000 Hematology J. 1: 15–27

  • Pollock JA, Zimonjic DB, Westervelt P, Popescu NC, Ley TJ . 2000 Blood 96: 827a

  • Redner RL, Rush EA, Faas S, Rudert WA, Corey SJ . 1996 Blood 87: 882–886

  • Rousselot P, Hardas B, Castaigne S, Dejean A, de The H, Degos L, Farzaneh F, Chomienne C . 1994 Oncogene 9: 545–551

  • Sachs L . 1978 Nature 274: 535–539

  • Sainty D, Liso V, Cantu-Rajnoldi A, Head D, Mozziconacci MJ, Arnoulet C, Benattar L, Fenu S, Mancini M, Duchayne E, Mahon FX, Gutierrez N, Birg F, Biondi A, Grimwade D, Lafage-Pochitaloff M, Hagemeijer A, Flandrin G . 2000 Blood 96: 1287–1296

  • Seale J, Delva L, Renesto P, Balitrand N, Dombret H, Scrobohaci ML, Degos L, Paul P, Chomienne C . 1996 Leukemia 10: 95–101

  • Shao W, Benedetti L, Iamph WW, Nervi C, Miller Jr WH . 1997 Blood 89: 4282–4289

  • Slack JL, Yu M . 1998 Blood 91: 3347–3356

  • Slack JL, Arthur DC, Lawrence D, Mrozek K, Mayer RJ, Davey FR, Tantravahi R, Pettenati MJ, Bihner S, Carroll AJ, Rao KW, Schiffer CA, Bloomfield CD . 1997 J. Clin. Oncol. 15: 1786–1795

  • Tosi P, Visani G, Gibellini D, Zauli G, Ottoviani E, Cenacchi A, Gamberi B, Manfrois S, Marchisio M, Turas S . 1994 Leukemia & Lymphoma 14: 503–507

  • Thomas X, Dombret H, Cordonnier C, Pigneux A, Gardin C, Guerci A, Vekhoff A, Sadoun A, Stamatoullas A, Fegueux N, Maloisel F, Cahn JY, Reman O, Gratecos N, Berthou C, Huguet F, Kotoucek P, Travade P, Buzyn A, de Revel T, Vilque JP, Naccache P, Chomienne C, Degos L, Fenaux P . for the European APL Group 2000 Leukemia 14: 1006–1013

  • Wang ZG, Delva L, Gaboli M, Rivi M, Giorgio M, Cordon-Cardo C, Grosveld F, Pandolfi PP . 1998 Science 279: 1547–1551

  • Ward AC, Loeb DM, Soede Bobok AA, Touw IP, Friedman AD . 2000 Leukemia 14: 973–990

  • Warrel Jr R, De The H, Wang ZY, Degos L . 1993 N. Engl. J. Med. 329: 177

  • Warrel RP, He LZ, Richon V, Calleja E, Pandolfi PP . 1998 J. Natl. Cancer Inst. 90: 1621–1625

  • Zhu J, Gianni M, Kopf E, Honore N, Chelbi-Alix M, Koken M, Quignon F, Rochette-Egly C, De The H . 1999 Proc. Natl. Acad. Sci. USA 21: 14807–14812

Download references

Author information

Authors and Affiliations

  1. Hopital Saint-Louis, Paris, Institute of Hematology, INSERM E 00-03, France

    Bruno Cassinat & Christine Chomienne

Authors
  1. Bruno Cassinat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christine Chomienne
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cassinat, B., Chomienne, C. Biological features of primary APL blasts: their relevance to the understanding of granulopoiesis, leukemogenesis and patient management. Oncogene 20, 7154–7160 (2001). https://doi.org/10.1038/sj.onc.1204761

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204761

Keywords

This article is cited by

Search

Advanced search

Quick links